{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Food and Drug Administration (USA) : Questions médicales les plus fréquentes",
"headline": "Food and Drug Administration (USA) : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Food and Drug Administration (USA) : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-11",
"dateModified": "2026-08-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Food and Drug Administration (USA)"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Public Health Service (USA)",
"url": "https://questionsmedicales.fr/mesh/D014492",
"about": {
"@type": "MedicalCondition",
"name": "Public Health Service (USA)",
"code": {
"@type": "MedicalCode",
"code": "D014492",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.540.348.500.500.600.650"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Food and Drug Administration (USA)",
"alternateName": "United States Food and Drug Administration",
"code": {
"@type": "MedicalCode",
"code": "D014486",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yu Wang",
"url": "https://questionsmedicales.fr/author/Yu%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Renaissance School of Medicne at Stony Brook University, Stony Brook, New York."
}
},
{
"@type": "Person",
"name": "Shari R Lipner",
"url": "https://questionsmedicales.fr/author/Shari%20R%20Lipner",
"affiliation": {
"@type": "Organization",
"name": "Weill Cornell Medicine, Department of Dermatology, New York, NY, United States."
}
},
{
"@type": "Person",
"name": "Ashwin Kamath",
"url": "https://questionsmedicales.fr/author/Ashwin%20Kamath",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India. ashwin.kamath@manipal.edu."
}
},
{
"@type": "Person",
"name": "Aaron S Kesselheim",
"url": "https://questionsmedicales.fr/author/Aaron%20S%20Kesselheim",
"affiliation": {
"@type": "Organization",
"name": "Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA; Harvard Medical School Center for Bioethics, Boston, MA."
}
},
{
"@type": "Person",
"name": "Gilbert J Burckart",
"url": "https://questionsmedicales.fr/author/Gilbert%20J%20Burckart",
"affiliation": {
"@type": "Organization",
"name": "Office of Clinical Pharmacology, United States Food and Drug Administration, Silver Spring, MD. Electronic address: Gilbert.Burckart@fda.hhs.gov."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Drug-associated congenital anomalies of the external ear identified in the United States food and drug administration adverse event reporting system database.",
"datePublished": "2024-10-09",
"url": "https://questionsmedicales.fr/article/39384812",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-74744-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluating the accuracy of Chat Generative Pre-trained Transformer version 4 (ChatGPT-4) responses to United States Food and Drug Administration (FDA) frequently asked questions about dental amalgam.",
"datePublished": "2024-05-24",
"url": "https://questionsmedicales.fr/article/38789962",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12903-024-04358-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "The United States Food and Drug Administration's Platform Technology Designation to Expedite the Development of Drugs.",
"datePublished": "2024-07-10",
"url": "https://questionsmedicales.fr/article/39065616",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/pharmaceutics16070918"
}
},
{
"@type": "ScholarlyArticle",
"name": "Liver injury in children: signal analysis of suspected drugs based on the food and drug administration adverse event reporting system.",
"datePublished": "2023-09-28",
"url": "https://questionsmedicales.fr/article/37770847",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12887-023-04097-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characteristics of race/ethnicity in trials leading to anti-rheumatic drug approval for inflammatory arthritis by the US Food and Drug Administration.",
"datePublished": "2023-10-18",
"url": "https://questionsmedicales.fr/article/37854006",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1756-185X.14944"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Organisations et économie des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D004472"
},
{
"@type": "ListItem",
"position": 3,
"name": "Organismes",
"item": "https://questionsmedicales.fr/mesh/D009938"
},
{
"@type": "ListItem",
"position": 4,
"name": "Gouvernement",
"item": "https://questionsmedicales.fr/mesh/D006076"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agences gouvernementale américaines",
"item": "https://questionsmedicales.fr/mesh/D037041"
},
{
"@type": "ListItem",
"position": 6,
"name": "Department of Health and Human Services (USA)",
"item": "https://questionsmedicales.fr/mesh/D014483"
},
{
"@type": "ListItem",
"position": 7,
"name": "Public Health Service (USA)",
"item": "https://questionsmedicales.fr/mesh/D014492"
},
{
"@type": "ListItem",
"position": 8,
"name": "Food and Drug Administration (USA)",
"item": "https://questionsmedicales.fr/mesh/D014486"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Food and Drug Administration (USA) - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Food and Drug Administration (USA)",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cosmétiques",
"headline": "Cosmétiques sur Food and Drug Administration (USA)",
"description": "La FDA régule-t-elle les cosmétiques ?\nQuels sont les ingrédients interdits dans les cosmétiques ?\nLes cosmétiques doivent-ils être approuvés par la FDA ?\nComment la FDA surveille-t-elle les cosmétiques ?\nQue faire en cas de réaction allergique à un cosmétique ?",
"url": "https://questionsmedicales.fr/mesh/D014486#section-cosmétiques"
},
{
"@type": "MedicalWebPage",
"name": "Dispositifs médicaux",
"headline": "Dispositifs médicaux sur Food and Drug Administration (USA)",
"description": "Quels types de dispositifs médicaux la FDA régule-t-elle ?\nComment la FDA classe les dispositifs médicaux ?\nQu'est-ce qu'une 510(k) ?\nQuel est le processus d'approbation des dispositifs médicaux ?\nQue fait la FDA pour surveiller les dispositifs après leur mise sur le marché ?",
"url": "https://questionsmedicales.fr/mesh/D014486#section-dispositifs médicaux"
},
{
"@type": "MedicalWebPage",
"name": "Sécurité alimentaire",
"headline": "Sécurité alimentaire sur Food and Drug Administration (USA)",
"description": "Quel est le rôle de la FDA en matière de sécurité alimentaire ?\nComment la FDA inspecte-t-elle les installations alimentaires ?\nQu'est-ce que le HACCP ?\nQuels aliments sont régulés par la FDA ?\nQue fait la FDA en cas de contamination alimentaire ?",
"url": "https://questionsmedicales.fr/mesh/D014486#section-sécurité alimentaire"
},
{
"@type": "MedicalWebPage",
"name": "Régulation des médicaments",
"headline": "Régulation des médicaments sur Food and Drug Administration (USA)",
"description": "Quel est le rôle principal de la FDA ?\nComment la FDA teste les nouveaux médicaments ?\nQu'est-ce qu'une NDA ?\nQuels types de médicaments la FDA régule-t-elle ?\nQue signifie 'approbation accélérée' ?",
"url": "https://questionsmedicales.fr/mesh/D014486#section-régulation des médicaments"
},
{
"@type": "MedicalWebPage",
"name": "Éducation et sensibilisation",
"headline": "Éducation et sensibilisation sur Food and Drug Administration (USA)",
"description": "Comment la FDA informe-t-elle le public ?\nQuelles ressources la FDA offre-t-elle aux professionnels de santé ?\nComment la FDA traite-t-elle les plaintes des consommateurs ?\nQu'est-ce que le programme REMS ?\nComment la FDA collabore-t-elle avec d'autres agences ?",
"url": "https://questionsmedicales.fr/mesh/D014486#section-éducation et sensibilisation"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "La FDA régule-t-elle les cosmétiques ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la FDA régule les cosmétiques pour garantir leur sécurité et leur étiquetage."
}
},
{
"@type": "Question",
"name": "Quels sont les ingrédients interdits dans les cosmétiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "La FDA interdit certains ingrédients jugés dangereux pour la santé dans les cosmétiques."
}
},
{
"@type": "Question",
"name": "Les cosmétiques doivent-ils être approuvés par la FDA ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les cosmétiques ne nécessitent pas d'approbation préalable, mais doivent être sûrs."
}
},
{
"@type": "Question",
"name": "Comment la FDA surveille-t-elle les cosmétiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La FDA surveille les cosmétiques via des inspections et des rapports de consommateurs."
}
},
{
"@type": "Question",
"name": "Que faire en cas de réaction allergique à un cosmétique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Signalez la réaction à la FDA et consultez un professionnel de santé pour des conseils."
}
},
{
"@type": "Question",
"name": "Quels types de dispositifs médicaux la FDA régule-t-elle ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "La FDA régule les dispositifs allant des bandages aux équipements chirurgicaux complexes."
}
},
{
"@type": "Question",
"name": "Comment la FDA classe les dispositifs médicaux ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les dispositifs sont classés en trois catégories selon leur risque : I, II, III."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une 510(k) ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une 510(k) est une demande pour prouver qu'un dispositif est équivalent à un produit déjà approuvé."
}
},
{
"@type": "Question",
"name": "Quel est le processus d'approbation des dispositifs médicaux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le processus inclut des études de sécurité, des essais cliniques et une évaluation par la FDA."
}
},
{
"@type": "Question",
"name": "Que fait la FDA pour surveiller les dispositifs après leur mise sur le marché ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La FDA surveille les dispositifs via des rapports d'événements indésirables et des inspections."
}
},
{
"@type": "Question",
"name": "Quel est le rôle de la FDA en matière de sécurité alimentaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La FDA surveille la sécurité des aliments pour prévenir les maladies d'origine alimentaire."
}
},
{
"@type": "Question",
"name": "Comment la FDA inspecte-t-elle les installations alimentaires ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "La FDA effectue des inspections régulières pour s'assurer du respect des normes de sécurité."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que le HACCP ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le HACCP (Hazard Analysis Critical Control Point) est un système de gestion de la sécurité alimentaire."
}
},
{
"@type": "Question",
"name": "Quels aliments sont régulés par la FDA ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La FDA régule la plupart des aliments, y compris les produits laitiers, les fruits et légumes."
}
},
{
"@type": "Question",
"name": "Que fait la FDA en cas de contamination alimentaire ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La FDA émet des rappels de produits et des alertes pour protéger le public."
}
},
{
"@type": "Question",
"name": "Quel est le rôle principal de la FDA ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La FDA évalue et approuve les médicaments pour garantir leur sécurité et efficacité."
}
},
{
"@type": "Question",
"name": "Comment la FDA teste les nouveaux médicaments ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La FDA exige des essais cliniques en plusieurs phases avant l'approbation."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une NDA ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une NDA (New Drug Application) est une demande d'approbation pour un nouveau médicament."
}
},
{
"@type": "Question",
"name": "Quels types de médicaments la FDA régule-t-elle ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La FDA régule les médicaments sur ordonnance, en vente libre et les biologiques."
}
},
{
"@type": "Question",
"name": "Que signifie 'approbation accélérée' ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un processus qui permet une approbation rapide pour des médicaments traitant des maladies graves."
}
},
{
"@type": "Question",
"name": "Comment la FDA informe-t-elle le public ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "La FDA publie des informations sur son site web et via des campagnes de sensibilisation."
}
},
{
"@type": "Question",
"name": "Quelles ressources la FDA offre-t-elle aux professionnels de santé ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La FDA fournit des guides, des études et des mises à jour sur les produits régulés."
}
},
{
"@type": "Question",
"name": "Comment la FDA traite-t-elle les plaintes des consommateurs ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La FDA examine les plaintes et peut enquêter sur les produits signalés comme dangereux."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que le programme REMS ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le REMS (Risk Evaluation and Mitigation Strategy) est un programme pour gérer les risques des médicaments."
}
},
{
"@type": "Question",
"name": "Comment la FDA collabore-t-elle avec d'autres agences ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La FDA collabore avec des agences nationales et internationales pour harmoniser les régulations."
}
}
]
}
]
}
Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA; Harvard Medical School Center for Bioethics, Boston, MA.
Publications dans "Food and Drug Administration (USA)" :
Congenital anomalies of the external ear can have a significant impact on a child's development and quality of life. While genetic factors play a crucial role in the etiology of these anomalies, envir...
The use of artificial intelligence in the field of health sciences is becoming widespread. It is known that patients benefit from artificial intelligence applications on various health issues, especia...
The purpose of this study was to the frequently asked questions about dental amalgam, as determined by the United States Food and Drug Administration (FDA), which is one of these information resources...
The questions were directed to ChatGPT-4 on May 8th and May 16th, 2023, and the responses were recorded and compared at the word and meaning levels using ChatGPT. The answers from the FDA webpage were...
ChatGPT-4 provided similar responses at one-week intervals. In comparison with FDA guidance, it provided answers with similar information content to frequently asked questions. However, although there...
The findings of this study indicate that ChatGPT-4, an artificial intelligence based application, encompasses current and accurate information regarding dental amalgam and its removal, providing it to...
Drug development costs can be significantly reduced if proven "platform" technologies are allowed to be used without having to validate their use. The most recent US Food and Drug Administration (FDA)...
Evidence of drug-induced liver injury is abundant in adults but is lacking in children. Our aim was to identify suspected drug signals associated with pediatric liver injury....
Hepatic adverse events (HAEs) among children reported in the Food and Drug Administration Adverse Event Reporting System were analyzed. A descriptive analysis was performed to summarize pediatric HAEs...
Here, 14,143 pediatric cases were reported, specifically 49.6% in males, 45.1% in females, and 5.2% unknown. Most patients (68.8%) were 6-18 years old. Hospitalization ranked first among definite outc...
The hepatotoxic risk associated with 264 signals needs to be noted in practice. The causality of hepatotoxicity and mechanism among new signals should be verified with preclinical and clinical studies...
Presenting the racial/ethnic representation in clinical trials leading to new approvals of inflammatory arthritis (IA) by the US Food and Drug Administration (FDA) to determine the extent of racial/et...
Pivotal trials supporting the approval of new indications from July 2012 to June 2022 were collected from Drugs@FDA, the FDA-approved drugs database. More details were then identified by searching Pub...
From 2012 to 2022, 34 new approvals were identified based on 59 clinical trials. The Black was consistently underrepresented in all subtypes of IA and drugs, while the White was overrepresented compar...
Despite many efforts to eliminate racial/ethnic disparities, the Black was consistently underrepresented in pivotal clinical trials compared to the 2020 US national race/ethnicity distribution data. T...
The dynamic and continuously evolving field of ophthalmology necessitates rigorous regulatory oversight in the United States. This review outlines the multifaceted Food and Drug Administration's (FDA)...
Biosimilars are clinically equivalent to branded products yet cost significantly less. Interchangeability is a US Food and Drug Administration (FDA) designation that allows generic drugs to be substit...
Building on pharmacy auto-substitution processes with therapeutic interchange, Plan-Do-Study-Act methodology was used to automate conversions from reference biological products to Pharmacy and Therape...
Systematic pharmacy-driven conversion to biosimilar products improved over cycles 1 and 2 from baseline: 1.8% to 90.3% for rituximab, 9.2% to 89.7% for trastuzumab, and 20.5% to 96.1% for bevacizumab....
Pharmacy-driven auto-substitution of biosimilar products results in rapid and statistically significant biosimilar adoption. The pharmacy-based substitution approach was found to be far more effective...
The Omnibus Budget Bill, known as H. R. 2471, passed through Congress on March 10, 2022, and was eventually signed by President Biden on March 15, 2022. This bill amended the Federal Food, Drug, and C...
This study aims to examine the public perceptions of the Omnibus Bill that regulates synthetic nicotine products as tobacco products on Twitter (rebranded as X)....
Through the X streaming application programming interface, we collected and identified 964 tweets related to the Omnibus Bill on synthetic nicotine between March 8, 2022, and April 13, 2022. The longi...
Between March 8, 2022, and April 13, 2022, we identified 964 tweets related to the Omnibus Bill regulating synthetic nicotine. Our longitudinal trend analysis showed a spike in the number of tweets re...
We observed a more negative sentiment toward the bill on X, largely due to users believing it would lead users back to smoking and negatively impact small vape businesses. This study provides insight ...
We aimed to ascertain the frequency and types of Food and Drug Administration (FDA)-identified clinical outcome assessment (COA) violations in US pharmaceutical promotional materials from 2013 to 2021...
Warning letters (WLs) and untitled letters (ULs) issued by the FDA's Office of Prescription Drug Promotion were reviewed for COA violations and classified by their type: (1) COA measure not fit for pu...
From 2013 to 2021, the FDA issued 22 WLs and 65 ULs. Year 2013 showed the highest number of letters issued (n = 24). Of the total 87 letters reviewed, 22 (25%) contained a COA violation, consisting of...
Overall, the absolute number of WLs and ULs issued declined when comparing 2006 to 2012 with 2013 to 2021. Despite the overall reduction, this review still identified 25% of letters citing COA infring...
There has been a surge in academic and business interest in software as a medical device (SaMD). SaMD enables medical professionals to streamline existing medical practices and make innovative medical...
This study aims to review the landscape of SaMD in response to increasing interest in SaMD within health systems and regulation. The objectives of the study are to (1) clarify the innovation process o...
We collected product information on 581 US Food and Drug Administration-approved SaMDs from the OpenFDA website and 268 company profiles of the corresponding manufacturers from Crunchbase, Bloomberg, ...
The current SaMD industry is highly concentrated in medical image processing and radiological analysis. Incumbents in the medical device industry currently lead the market and focus on incremental inn...
SaMD, as an industry, is nascent and dominated by incremental innovation. The innovation process of the present SaMD industry is shaped by data accessibility, which is key to building disruptive innov...